![Theodore Schroeder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theodore Schroeder
Director/Board Member at
PHATHOM PHARMACEUTICALS, INC.
Net worth: 75 961 $ as of 2026-06-29
Profile
Theodore R.
Schroeder was the founder of Mallinckrodt Hospital Products, Inc., founded in 2004, where the titles held included President, Chief Executive Officer & Director from 2004 to 2014.
Mr. Schroeder was the founder of Zavante Therapeutics, Inc., founded in 2015, where the titles held included President, Chief Executive Officer & Director from 2015 to 2018.
Current jobs include Director at Sharp Hospital Foundation and Independent Director at Phathom Pharmaceuticals, Inc. starting in 2025.
Former jobs include Vice Chairman at Antimicrobials Working Group from 2021 to 2023; Chairman at Biocom, Inc. from 2015 to 2017; Senior Director-Marketing Hospital Products at Dura Pharmaceuticals, Inc. in 2000; Director at Nabriva Therapeutics Plc from 2023 to 2025; Independent Director at Collegium Pharmaceutical, Inc. from 2016 to 2021; Director at Hyperion Therapeutics, Inc. from 2014 to 2015; Director at Incline Therapeutics, Inc.; Independent Director at Cidara Therapeutics, Inc. from 2014 to 2026; Independent Director at Trius Therapeutics, Inc. from 2012 to 2013; Independent Director at Otonomy, Inc. from 2015 to 2023; Principal at Bristol Myers Squibb Co.; Senior VP-North American Sales & Marketing at Elan Pharmaceuticals LLC from 2002 to 2004.
Education includes undergraduate studies at Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-18 | 7,001 ( 0.01% ) | 75 961 $ | 2026-06-29 |
Theodore Schroeder active positions
| Companies | Position | Start |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Director/Board Member | 2025-04-15 |
Sharp Hospital Foundation | Director/Board Member | - |
Former positions of Theodore Schroeder
| Companies | Position | End |
|---|---|---|
| CIDARA THERAPEUTICS | Director/Board Member | 2026-01-06 |
| NABRIVA THERAPEUTICS PLC | Chief Executive Officer | 2023-01-14 |
| OTONOMY | Director/Board Member | 2023-02-14 |
Antimicrobials Working Group
 Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Operates as an association of antimicrobials and diagnostics companies | Chairman | 2023-01-16 |
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2021-05-20 |
Training of Theodore Schroeder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
49
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Sharp Hospital Foundation | |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Antimicrobials Working Group
Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Operates as an association of antimicrobials and diagnostics companies | Commercial Services |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Theodore Schroeder
